Windtree Therapeutics (WINT) Earnings Date, Estimates & Call Transcripts $3.20 +0.03 (+0.95%) (As of 09/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 19) -$20.91 Missed By -$12.80 Consensus EPS (Aug. 19) -$8.11 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueWINT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.WINT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Windtree Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($8.11)($8.11)($8.11)Q3 20241($2.27)($2.27)($2.27)Q4 20241($1.14)($1.14)($1.14)WINT Earnings Date and InformationWindtree Therapeutics last posted its earnings data on August 19th, 2024. The reported ($20.91) EPS for the quarter, missing the consensus estimate of ($8.11) by $12.80. Windtree Therapeutics has generated ($36.29) earnings per share over the last year (($36.29) diluted earnings per share). Earnings for Windtree Therapeutics are expected to grow in the coming year, from ($2.38) to ($2.13) per share. Windtree Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Windtree Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/19/2024-($8.11)($20.91)($12.80)($20.91)--5/15/2024Q1 2024-($9.25)($9.25)($40.48)--4/16/2024Q4 2023-($13.31)($13.31)($13.31)--11/9/2023Q3 2023-($15.48)($15.48)($0.86)--8/7/2023Q2 2023-($29.52)($29.52)($1.64)--5/15/2023Q1 2023-($85.68)($85.68)($4.76)--Why Are Buffett, Bezos, and Musk Fleeing Tech? Here's What To Do Now... (Ad)The financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumping their tech stocks at a pace we've never seen before. What do they know that's pushing them out? One that Fortune is calling:"The Great Cash Out".Click here to get the details now.4/3/2023Q4 2022($189.00)($234.18)($45.18)($13.01)--11/14/2022Q3 2022($540.00)($234.00)+$306.00($0.13)--8/11/2022Q2 2022($99.00)($171.00)($72.00)$0.21--5/5/2022Q1 2022($279.00)($261.00)+$18.00($0.29)--3/31/2022Q4 2021($297.00)($414.00)($117.00)($0.46)--11/10/2021Q3 2021($261.00)($279.00)($18.00)($0.31)--8/5/2021Q2 2021($441.00)($1,278.00)($837.00)($1.42)--5/13/2021Q1 2021($270.00)($459.00)($189.00)($0.51)--3/28/2021Q4 2020($405.00)($387.00)+$18.00($0.44)--11/16/2020Q3 2020($441.00)($486.00)($45.00)($0.54)--11/16/2020Q3 2020($441.00)($486.00)($45.00)($0.54)--8/13/2020Q2 2020-($567.00)($567.00)($0.63)--8/13/2020Q2 2020($324.00)($567.00)($243.00)($0.63)--5/14/2020Q1 2020-($432.00)($432.00)($0.48)--5/14/2020Q1 2020-($432.00)($432.00)($0.48)--4/2/2020Q4 2019-($567.00)($567.00)($0.63)--4/2/2020Q4 2019-($567.00)($567.00)($0.63)--11/14/2019Q3 2019-($594.00)($594.00)($0.66)--11/14/2019Q3 2019-($594.00)($594.00)($0.22)-- Windtree Therapeutics Earnings - Frequently Asked Questions When is Windtree Therapeutics's earnings date? Windtree Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on WINT's earnings history. Did Windtree Therapeutics beat their earnings estimates last quarter? In the previous quarter, Windtree Therapeutics (NASDAQ:WINT) missed the analysts' consensus estimate of ($8.11) by $12.80 with a reported earnings per share (EPS) of ($20.91). Learn more on analysts' earnings estimate vs. WINT's actual earnings. How much profit does Windtree Therapeutics generate each year? Windtree Therapeutics (NASDAQ:WINT) has a recorded net income of -$20.29 million. WINT has generated -$36.29 earnings per share over the last four quarters. What is Windtree Therapeutics's EPS forecast for next year? Windtree Therapeutics's earnings are expected to grow from ($2.38) per share to ($2.13) per share in the next year. More Earnings Resources from MarketBeat Related Companies: COEP Earnings Date APTO Earnings Date ALBT Earnings Date CHRO Earnings Date TTNP Earnings Date BCDA Earnings Date CELZ Earnings Date FRTX Earnings Date PALI Earnings Date NSTGQ Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:WINT) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredI’m giving you the name of this investment for freeNow that the Federal Reserve lowered interest rates, this investment could easily go up 50%.Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Windtree Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
